SEC Comment Letter for Cryoport, Inc. (CYRX) (CIK 0001124524) (CYRX) — May 9, 2012
Cryoport, Inc. (CYRX) (CIK 0001124524)
Date: May 9, 2012 · CIK: 0001124524 · Accession: 0000000000-12-024108
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-180326
Referenced dates: April 12, 2012, April 12, 2012
Letter
May 7 , 2012 Via E -mail Robert Stefanovich Chief Financial Officer Cryoport, Inc. 225 Broadway, Suite 430 San Diego, CA 92101
Re: Cryoport, Inc. Amendment No. 1 to Registration Statement on Form S-1 Filed April 27 , 2012 File No. 333-180326
Dear Mr. St efanovich :
We have reviewed your amended registration statement and have the following comments.
General
1. We note your response to comment one in our letter dated April 12, 2012, where you state among other things that “the current public information requirements of Rule 144(c) of the Securities Act had been satisfied” with respect to the shares of outstanding common stock eligible for resale under Rule 144(b)(1). Please tell us how you have satisfied the requirements of Rule 144(c)(1)(ii) under the Securities Act. Please note that we were unable to locate on your website any information required to be submitted and posted pursuant to Rule 4 05 of Regulation S -T.
Security Ownership of Certain Beneficial Owners and Management, page 60
2. We note your revised disclosure in response to comment two in our letter dated April 12, 2012. Please revise your tabular disclosure to identify the Deerfield Funds, and not James E. Flynn, as beneficial owners.
Signatures
3. Please have the registration statement signed by the parties identified in Instruction 1 to Signatures in the Form S -1. Refer to Rule 471 under the Securities Act and Section 6(a) of the Se curities Act.
Robert Stefanovich Cryoport, Inc. May 7 , 2012 Page 2
Please contact Sherry Haywood, Staff Attorney at (202) 551 -3345 or, in her absence, Era Anagnosti, Senior Staff Attorney , at (202) 551 -3369 with any questions.
Sincerely,
/s/ Era Anagnosti, for
Show Raw Text
May 7 , 2012 Via E -mail Robert Stefanovich Chief Financial Officer Cryoport, Inc. 225 Broadway, Suite 430 San Diego, CA 92101 Re: Cryoport, Inc. Amendment No. 1 to Registration Statement on Form S-1 Filed April 27 , 2012 File No. 333-180326 Dear Mr. St efanovich : We have reviewed your amended registration statement and have the following comments. General 1. We note your response to comment one in our letter dated April 12, 2012, where you state among other things that “the current public information requirements of Rule 144(c) of the Securities Act had been satisfied” with respect to the shares of outstanding common stock eligible for resale under Rule 144(b)(1). Please tell us how you have satisfied the requirements of Rule 144(c)(1)(ii) under the Securities Act. Please note that we were unable to locate on your website any information required to be submitted and posted pursuant to Rule 4 05 of Regulation S -T. Security Ownership of Certain Beneficial Owners and Management, page 60 2. We note your revised disclosure in response to comment two in our letter dated April 12, 2012. Please revise your tabular disclosure to identify the Deerfield Funds, and not James E. Flynn, as beneficial owners. Signatures 3. Please have the registration statement signed by the parties identified in Instruction 1 to Signatures in the Form S -1. Refer to Rule 471 under the Securities Act and Section 6(a) of the Se curities Act. Robert Stefanovich Cryoport, Inc. May 7 , 2012 Page 2 Please contact Sherry Haywood, Staff Attorney at (202) 551 -3345 or, in her absence, Era Anagnosti, Senior Staff Attorney , at (202) 551 -3369 with any questions. Sincerely, /s/ Era Anagnosti, for Pamela Long Assistant Director cc: Via E -mail Mark Ziebell, Esq.